Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human PRKRA Protein, N-His

Catalog #:   YHB24901 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O75569
Protein length: Asn126-Lys313
Overview

Catalog No.

YHB24901

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asn126-Lys313

Predicted molecular weight

23.00 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O75569

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

PKR-associated protein X, Protein activator of the interferon-induced protein kinase, PACT, PRKRA, RAX, PKR-associating protein X, Interferon-inducible double-stranded RNA-dependent protein kinase activator A, Protein kinase, interferon-inducible double-stranded RNA-dependent activator

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human PRKRA Protein
References

Global translational regulation by Prkra: Is PKR no longer needed?, PMID:40378825

Decreased protein activator of interferon induced protein kinase (PRKRA) involved in menopause-related cholesterol metabolic disorders by regulating cholesterol biosynthesis., PMID:40349061

Prkra dimer senses double-stranded RNAs to dictate global translation efficiency., PMID:40280134

Exome sequencing identifies novel genes associated with cerebellar volume and microstructure., PMID:40025133

Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade., PMID:39991958

Calcium release from damaged lysosomes triggers stress granule formation for cell survival., PMID:39962896

Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's disease., PMID:39760821

Mutation in Prkra results in cerebellar abnormality and reduced eIF2α phosphorylation in a model of DYT-PRKRA., PMID:39512178

A frameshift mutation in the murine Prkra gene causes dystonia and exhibits abnormal cerebellar development and reduced eIF2α phosphorylation., PMID:38895245

Decreased Tiam1-mediated Rac1 activation is responsible for impaired directional persistence of chondrocyte migration in microtia., PMID:38837873

Dissecting genetic architecture of rare dystonia: genetic, molecular and clinical insights., PMID:38458754

Large-Scale Screening: Phenotypic and Mutational Spectrum in Isolated and Combined Dystonia Genes., PMID:38214203

Genetics and Pathogenesis of Dystonia., PMID:37738511

HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp., PMID:37710038

Exome-wide association study of treatment-resistant depression suggests novel treatment targets., PMID:37528149

Retrotransposon LINE-1 bodies in the cytoplasm of piRNA-deficient mouse spermatocytes: Ribonucleoproteins overcoming the integrated stress response., PMID:37307272

Prkra Mutation Alters mRNA Expression During Embryonic External Ear Development., PMID:37185168

Mapping the landscape of genetic dependencies in chordoma., PMID:37024492

Antisense lncRNA CHROMR is linked to glioma patient survival., PMID:36950523

Luteolin protects DYT-PRKRA cells from apoptosis by suppressing PKR activation., PMID:36874028

Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis., PMID:36755464

Ribonucleoprotein condensation driven by retrotransposon LINE-1 sustains RNA integrity and translation in mouse spermatocytes., PMID:36712121

Delving into the Heterogeneity of Different Breast Cancer Subtypes and the Prognostic Models Utilizing scRNA-Seq and Bulk RNA-Seq., PMID:36077333

PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation., PMID:35974143

Point Mutation in Prkra Alters miRNA Expression During Embryonic External Ear Development., PMID:35968958

Early-Onset Dystonia, Exacerbation With Fever, and Striatal Signal Changes: Emerging Phenotype of DYT-PRKRA., PMID:35914940

DYT-PRKRA Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon Induction., PMID:35625640

PACT establishes a posttranscriptional brake on mitochondrial biogenesis by promoting the maturation of miR-181c., PMID:35598827

Exome-wide analysis of copy number variation shows association of the human leukocyte antigen region with asthma in UK Biobank., PMID:35597955

Inhibiting the aberrant PACT-p53 axis activation ameliorates spinal cord ischaemia-reperfusion injury in rats., PMID:35421805

Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinformatical analysis., PMID:35116411

SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules., PMID:35075101

Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression., PMID:35035655

High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1)., PMID:34520479

Tremor in Primary Monogenic Dystonia., PMID:34264428

Regulation of PKR activation and apoptosis during oxidative stress by TRBP phosphorylation., PMID:34174402

Opposing forces fight over the same ground to regulate interferon signaling., PMID:34003254

PKR activity modulation by phosphomimetic mutations of serine residues located three aminoacids upstream of double-stranded RNA binding motifs., PMID:33911136

PRKRA-Related Disorders: Bilateral Striatal Degeneration in Addition to DYT16 Spectrum., PMID:33606314

Genotype-Phenotype Relations for Isolated Dystonia Genes: MDSGene Systematic Review., PMID:33502045

A genome-scale CRISPR screen reveals factors regulating Wnt-dependent renewal of mouse gastric epithelial cells., PMID:33479180

Opposite actions of two dsRNA-binding proteins PACT and TRBP on RIG-I mediated signaling., PMID:33459340

A pan-cancer atlas of somatic mutations in miRNA biogenesis genes., PMID:33406242

A tale of two proteins: PACT and PKR and their roles in inflammation., PMID:33387379

EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia., PMID:33236446

Combined dystonias: clinical and genetic updates., PMID:33099685

Dystonia 16 (DYT16) mutations in PACT cause dysregulated PKR activation and eIF2α signaling leading to a compromised stress response., PMID:33049316

A systems biology-driven approach to construct a comprehensive protein interaction network of influenza A virus with its host., PMID:32631335

PACT/PRKRA and p53 regulate transcriptional activity of DMRT1., PMID:32251494

PACT-mediated PKR activation acts as a hyperosmotic stress intensity sensor weakening osmoadaptation and enhancing inflammation., PMID:32175843

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human PRKRA Protein, N-His [YHB24901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only